Need a Safe, Private Abortion? Ask Charley.

On Tuesday, Sept. 12, reproductive health experts launched a new online chatbot named Charley to help abortion seekers in all 50 states find quick, accurate and confidential abortion information, tailored to their individual needs and circumstances.

Charley only asks for a user’s zip code and date of their last period to determine how far along they are in their pregnancy. Charley also makes referrals to medical and legal support services, as well as community support networks. Co-founded by former Planned Parenthood president Cecile Richards and the former head of Planned Parenthood’s digital department Tom Subak, Charley launched in partnership with INeedAnA.com, Plan C and the Miscarriage + Abortion (M+A) Hotline.

“There’s a lot of fear and confusion out there about how abortion is available, especially in restricted states, and there are different resources out there. But there hasn’t been a single resource that includes all the information. Charley does that,” said Elisa Wells, co-director of Plan C. “Charley walks people through their options and then directs them to the resources that are available to help them find more specific information.”

U.S. Clinicians Can Now Mail Abortion Pills to States Banning Abortion, Thanks to Shield Laws in Five States

Telemedicine abortion provider shield laws have led to significantly quicker shipping times for people living in restrictive states—from several weeks to several days—which is critical for this time-sensitive medical care.

Between mid-June and mid-July, seven Aid Access clinicians located across these five states mailed pills to 3,500 people located in states banning abortion. “It shows what people want,” said Julie F. Kaye, co-founder of the Abortion Coalition for Telemedicine Access

Without Roe, Abortion Pills Are More Important Than Ever. We Must Remove Barriers.

Since the fall of Roe, at least 66 clinics have stopped providing abortion care. Many people have found essential care by purchasing abortion pills online and having them delivered by mail.

As we continue into the post-Roe future, we must address the inequalities that limit these innovations in states where telehealth is legal, but also in states where it is illegal.

Supreme Court Blocks Fifth Circuit Ruling, Allowing Mifepristone to Stay on the Market as Case Proceeds

In a shadow docket ruling late on Friday, April 21, the Supreme Court has decided to block a previous ruling from the U.S. Court of Appeals for the Fifth Circuit from taking effect, allowing the abortion pill mifepristone to remain on the market under current rules.

“While SCOTUS offered temporary relief, the fate of a medication approved by the FDA more than 20 years ago should have never been before the Supreme Court to begin with,” said Kirsten Moore of Expanding Medication Abortion Access Project.

Circuit Court Rules Abortion Pill Can Remain on the Market, but With Limitations That Could Restrict Access

In a divided opinion issued late Wednesday, the U.S. Court of Appeals for the Fifth Circuit ruled that the abortion medication mifepristone will remain approved for use throughout the United States, but only up to seven weeks of pregnancy when a doctor dispenses the medication in person. This ruling, if allowed to stand and followed, would significantly impair access to abortion throughout the United States.

“The Fifth Circuit’s decision to roll back recent measures that have ensured greater access to medication abortion care undermines the FDA’s authority and science, all while real people pay the price,” said Morgan Hopkins, president of All* Above All.

Democratic AGs File Counter-Lawsuit to Expand Access to Abortion Pills

As people wait nervously for an anti-abortion judge to rule in a Texas lawsuit aimed at removing the abortion pill mifepristone from the market nationwide, Democratic attorneys general from a dozen states are fighting back with a lawsuit of their own.

On Feb. 24, attorneys general of Washington, Oregon, Arizona, Colorado, Connecticut, Delaware, Illinois, Michigan, Nevada, New Mexico, Rhode Island and Vermont sued the U.S. Food and Drug Administration (FDA), asking a Washington federal court to declare that mifepristone is safe and effective and that the FDA’s approval of mifepristone is lawful and valid. Experts see the lawsuit as an attempt to produce a contrary ruling from the Texas judge, whom observers predict will order the FDA to remove mifepristone from the market.

As Conservatives Try to Ban the Abortion Pill Mifepristone, New Research Shows Accessible Ulcer Drug Safely Ends Pregnancy Up to 12 Weeks

A Trump-appointed judge in Texas will soon decide whether to force the abortion pill mifepristone off the market in all 50 states.

While mifepristone’s future is shaky, women and pregnant people can still access misoprostol, a highly effective and medically safe method to end an early pregnancy.

Telehealth Providers Prepare for the Future

Providers of reproductive and gender-affirming care have long been pushing for an increase in the use of telemedicine. Patients want it too. Telehealth implementation comes with decreased costs, wait times and travel. For stigmatized issues like abortion and gender-affirming care, it also ensures patients and providers alike face less harassment and makes niche treatments more widely accessible.

To understand the telehealth landscape and how it impacts reproductive care, Ms. spoke with telehealth abortion, contraceptive, and gender-affirming care providers to understand how the fall of Roe has affected their work.